Jolana Marková

Sativex ^® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

Jolana Marková, Ute Essner, M. Marinelli et al. · International Journal of Neuroscience · 2018 · 144 citations

Pharmacy, Neurology, Pharmacotherapy +17

Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine.

G Waberzinek, Jolana Marková, Jiří Mastík · PubMed · 2007 · 19 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Terguride in Parkinsonism a multicenter trial

M Filipová, Václav Filip, Z Macek et al. · European Archives of Psychiatry and Clinical Neuroscience · 1988 · 17 citations

Medicine, Neurology, Pharmacology +11

Eight cycles of BEACOPP escalated compared with 4 cycles of BEACOPP escalated followed by 4 cycles of BEACOPP baseline with or without radiotherapy in patients in advanced stage Hodgkin lymphoma (HL): Final analysis of the HD12 trial of the German Hodgkin Study Group (GHSG)

V. Diehl, Heinz Haverkamp, R.P. Mueller et al. · Journal of Clinical Oncology · 2009 · 14 citations

Medicine, Hematology, Oncology +17